Clinical Trial Update: E-Five Registry: A World-Wide Registry With The Endeavor Zotarolimus Eluting Coronary Stent

View source ↗

Summary

The E-Five Registry, a worldwide study on the Endeavor zotarolimus-eluting coronary stent for coronary artery disease, has completed enrollment and posted resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Endeavor zotarolimus-eluting stent (zotarolimus)

Snippet

Sponsor: Medtronic Cardiac Rhythm and Heart Failure | Conditions: Coronary Artery Disease | Status: COMPLETED | Results posted: 2011-12-16